Europe Medical Aesthetic Devices Market Size (2024 - 2029)

The Europe medical aesthetic devices market is poised for growth, driven by factors such as the increasing prevalence of obesity, heightened awareness of aesthetic procedures, and the adoption of minimally invasive techniques. The market's expansion is supported by the resurgence of aesthetic procedures post-COVID-19 restrictions, which has boosted demand for these devices. Despite challenges like high procedure costs and limited reimbursement options, the market is expected to grow, fueled by the rising concern for appearance and the introduction of new products.

Market Size of Europe Medical Aesthetic Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Europe Medical Aesthetic Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 11.07 %
Market Concentration Medium

Major Players

Europe Medical Aesthetic Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe Medical Aesthetic Devices Market Analysis

Europe's medical aesthetic devices market is expected to witness a CAGR of 11.07% over the forecast period.

  • The COVID-19 pandemic significantly impacted the medical aesthetic devices market in Europe. While the percentage of admissions that returned to pre-pandemic levels increased to 33.8%, some areas, such as the Czech Republic, Romania, and Spain, encountered significant admissions restrictions, which slowed market growth. However, with the release of restrictions and the resumption of services, the number of aesthetic procedures in hospitals and clinics has increased, fueling demand for aesthetic devices and propelling the market growth.
  • Several factors are expected to boost market growth, including the rising prevalence of obesity, growing awareness of aesthetic procedures, and increasing adoption of minimally invasive techniques. The burden of the obese population was a key driver of market growth, as 25.9% of adults in England were obese in 2021, according to the Health Survey for England. Men (68.6%) were more likely to be overweight or obese than women (59%). The rising burden of obesity in the region is anticipated to increase demand for aesthetic surgeries and devices, thus boosting market growth.
  • The demand for cosmetic surgeries is also increasing, with liposuction and eyelid surgeries being popular procedures in Germany, Italy, and Spain, according to the International Society of Aesthetic Plastic Surgery. This growing trend of people's concern for appearance is expected to fuel the demand for aesthetic devices and bolster market growth. Moreover, the increasing numer of new product launches and approvals, such as Galderma's Alluzience in June 2021, is anticipated to drive market growth over the forecast period.
  • However, the high cost of aesthetic procedures and poor reimbursement scenarios are likely to impede market growth. Nevertheless, the market is expected to project growth over the forecast period, owing to factors such as the high burden of obesity and the growing number of aesthetic procedures.

Europe Medical Aesthetic Devices Industry Segmentation

As per the scope of the report, aesthetic devices refer to all medical devices that are used for various cosmetic procedures, which include plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., that are used for beautification, correction, and improvement of the body. Aesthetic procedures include both surgical and non-surgical procedures.

The Europe medical aesthetic devices market is segmented by type of devices (energy-based aesthetic devices (laser-based aesthetic devices, radiofrequency (RF)-based aesthetic devices, light-based aesthetic devices, and ultrasound aesthetic devices), non-energy based aesthetic devices (botulinum toxin, dermal fillers and aesthetic threads, chemical peels, microdermabrasion, and implants (facial implants, breast implants, and other implants), and other aesthetic devices), application (skin resurfacing and tightening, body contouring and cellulite reduction, hair removal, breast augmentation, and other applications), end-user (hospitals, clinics, and other end-users), and geography (United Kingdom, Germany, France, Italy, Spain, and Rest of Europe).

The report offers the value (in USD million) for the above segments.

By Type of Devices
Energy-Based Aesthetic Devices
Laser-based Aesthetic Devices
Radiofrequency (RF) Based Aesthetic Devices
Light-based Aesthetic Devices
Ultrasound Aesthetic Devices
Non-Energy-Based Aesthetic Device
Botulinum Toxin
Dermal Fillers and Aesthetic Threads
Chemical Peels
Microdermabrasion
Implants
Facial Implants
Breast Implants
Other Implants
Other Aesthetic Devices
By Application
Skin Resurfacing and Tightening
Body Contouring and Cellulite Reduction
Hair Removal
Breast Augmentation
Other Applications
By End-User
Hospitals
Clinics
Other End-Users
Geography
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Need A Different Region Or Segment?
Customize Now

Europe Medical Aesthetic Devices Market Size Summary

The European medical aesthetic devices market is poised for substantial growth, driven by a combination of factors such as the increasing prevalence of obesity, heightened awareness of aesthetic procedures, and the growing adoption of minimally invasive techniques. The market experienced a temporary setback due to the COVID-19 pandemic, which led to restrictions in certain countries, but has since rebounded with the resumption of services. The demand for cosmetic surgeries, particularly in countries like Germany, Italy, and Spain, is on the rise, with procedures such as liposuction and eyelid surgeries gaining popularity. This trend is further supported by the introduction of new products and approvals, which are expected to propel market growth over the forecast period. Despite challenges like high procedure costs and poor reimbursement scenarios, the market is anticipated to expand, fueled by the increasing number of aesthetic procedures and the high burden of obesity.

The breast implant segment within the medical aesthetic devices market is expected to witness significant growth, driven by the rising prevalence of breast cancer, growing awareness of physical appearance, and the availability of advanced breast implants. The increasing number of breast augmentation procedures in the region is contributing to this growth, as is the introduction of technologically advanced devices. Germany is expected to hold a significant market share due to its high burden of breast cancer, increasing aesthetic procedures, and a growing geriatric population. The market is characterized by moderate fragmentation, with both small and large players employing strategies such as partnerships and product approvals to maintain their positions. Key players include Abbvie Inc. (Allergan Inc.), Boston Scientific Corporation (Lumenis Inc.), Johnson and Johnson, Alma Lasers, and Galderma Pharmaceuticals, all of which are actively contributing to the market's expansion through innovative product launches and strategic collaborations.

Explore More

Europe Medical Aesthetic Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Obese Population

      2. 1.2.2 Increasing Awareness Regarding Aesthetic Procedures and Rising Adoption of Minimally Invasive Techniques

    3. 1.3 Market Restraints

      1. 1.3.1 Poor Reimbursement Scenario

      2. 1.3.2 High Cost of Aesthetic Procedures

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type of Devices

      1. 2.1.1 Energy-Based Aesthetic Devices

        1. 2.1.1.1 Laser-based Aesthetic Devices

        2. 2.1.1.2 Radiofrequency (RF) Based Aesthetic Devices

        3. 2.1.1.3 Light-based Aesthetic Devices

        4. 2.1.1.4 Ultrasound Aesthetic Devices

      2. 2.1.2 Non-Energy-Based Aesthetic Device

        1. 2.1.2.1 Botulinum Toxin

        2. 2.1.2.2 Dermal Fillers and Aesthetic Threads

        3. 2.1.2.3 Chemical Peels

        4. 2.1.2.4 Microdermabrasion

        5. 2.1.2.5 Implants

          1. 2.1.2.5.1 Facial Implants

          2. 2.1.2.5.2 Breast Implants

          3. 2.1.2.5.3 Other Implants

        6. 2.1.2.6 Other Aesthetic Devices

    2. 2.2 By Application

      1. 2.2.1 Skin Resurfacing and Tightening

      2. 2.2.2 Body Contouring and Cellulite Reduction

      3. 2.2.3 Hair Removal

      4. 2.2.4 Breast Augmentation

      5. 2.2.5 Other Applications

    3. 2.3 By End-User

      1. 2.3.1 Hospitals

      2. 2.3.2 Clinics

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 United Kingdom

      2. 2.4.2 Germany

      3. 2.4.3 France

      4. 2.4.4 Italy

      5. 2.4.5 Spain

      6. 2.4.6 Rest of Europe

Europe Medical Aesthetic Devices Market Size FAQs

The Europe Medical Aesthetic Devices Market is projected to register a CAGR of 11.07% during the forecast period (2024-2029)

Johnson and Johnson, Alma Lasers, Galderma SA, Abbvie Inc (Allergan Inc.) and Boston Scientific Corporation (Lumenis Inc.) are the major companies operating in the Europe Medical Aesthetic Devices Market.

Europe Medical Aesthetic Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)